For CD4 + T cells, CD25 expression was markedly reduced by AD-MSCs, decreasing from 61.5–80.2% in monoculture to 12.8–26.7% (early) and 10.1–18.6% (late) co-cultures in DMEM. This evidence concerns the gene CD4 and Alzheimer disease.